Brief: Eledon Pharmaceuticals Highlights Recent Business Milestones And Provides 2024 Outlook
04/01/2024 22:54
Jan 4 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS HIGHLIGHTS RECENT BUSINESS
MILESTONES AND
PROVIDES 2024 OUTLOOK
* ELEDON PHARMACEUTICALS- SEES UPDATED INTERIM CLINICAL DATA
FROM
ONGOING PHASE 1B TRIAL OF TEGOPRUBART IN KIDNEY TRANSPLANTATION
IN FIRST HALF 2024
Source text for Eikon: ID:nGNX7wGvBd
Further company coverage: ELDN.O
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial